INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 175 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,727,000 | -26.8% | 27,057 | -8.3% | 0.00% | -25.0% |
| Q3 2018 | $3,727,000 | +977.2% | 29,492 | +1172.9% | 0.00% | – |
| Q4 2015 | $346,000 | -9.9% | 2,317 | 0.0% | 0.00% | – |
| Q3 2015 | $384,000 | -28.9% | 2,317 | +3.5% | 0.00% | -100.0% |
| Q2 2015 | $540,000 | -3.7% | 2,239 | +12.6% | 0.00% | 0.0% |
| Q1 2015 | $561,000 | +81.0% | 1,988 | 0.0% | 0.00% | – |
| Q4 2014 | $310,000 | -31.6% | 1,988 | +3.9% | 0.00% | -100.0% |
| Q3 2014 | $453,000 | 0.0% | 1,913 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $453,000 | -77.5% | 1,913 | -68.7% | 0.00% | -50.0% |
| Q1 2014 | $2,015,000 | – | 6,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |